PFBT
LGND icon

Parkside Financial Bank & Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.7K Buy
97
+18
+23% +$4.24K ﹤0.01% 1218
2026
Q1 		$15.8K Buy
79
+10
+14% +$1.98K ﹤0.01% 1407
2025
Q4 		$13K Buy
69
+10
+17% +$1.92K ﹤0.01% 1466
2025
Q3 		$10.5K Buy
59
+6
+11% +$892 ﹤0.01% 1502
2025
Q2 		$6.03K Buy
53
+8
+18% +$855 ﹤0.01% 1641
2025
Q1 		$4.73K Buy
+45
New +$5.09K ﹤0.01% 1648
2024
Q4 		– Sell
-10
Closed -$1K – 2164
2024
Q3 		$1K Buy
+10
New +$1.01K ﹤0.01% 1705
2023
Q4 		– Sell
-2
Closed -$120 – 2132
2023
Q3 		$120 Sell
2
-48
-96% -$3.16K ﹤0.01% 2014
2023
Q2 		$3.6K Hold
50
– – ﹤0.01% 1484
2023
Q1 		$3.68K Hold
50
– – ﹤0.01% 1480
2022
Q4 		$3.34K Sell
50
-29
-37% -$1.89K ﹤0.01% 1490
2022
Q3 		$4K Buy
79
+13
+20% +$764 ﹤0.01% 1314
2022
Q2 		$4K Buy
66
+61
+1,220% +$3.46K ﹤0.01% 1345
2022
Q1 		$0 Buy
+5
New +$363 ﹤0.01% 1877
2021
Q4 		– Sell
-77
Closed -$7K – 1862
2021
Q3 		$7K Buy
+77
New +$5.96K ﹤0.01% 1096
2018
Q4 		– Sell
-27
Closed -$5K – 1511
2018
Q3 		$5K Hold
27
– – ﹤0.01% 912
2018
Q2 		$4K Hold
27
– – ﹤0.01% 928
2018
Q1 		$3K Buy
27
+6
+29% +$593 ﹤0.01% 938
2017
Q4 		$2K Hold
21
– – ﹤0.01% 989
2017
Q3 		$2K Hold
21
– – ﹤0.01% 985
2017
Q2 		$2K Hold
21
– – ﹤0.01% 990
2017
Q1 		$1K Buy
21
+5
+31% +$329 ﹤0.01% 1140
2016
Q4 		$1K Buy
+16
New +$1.01K ﹤0.01% 1134

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jupiter Topco
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's LGND Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Ligand Pharmaceuticals (LGND) stake by 23% in Q2 2026, buying an estimated $4.24K and bringing the position to 97 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

Parkside Financial Bank & Trust first reported a position in LGND in Q4 2016 and has held it in 23 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Parkside Financial Bank & Trust held 97 shares of Ligand Pharmaceuticals worth $30.7K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 18 Ligand Pharmaceuticals shares in Q2 2026, an estimated $4.24K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1218 holding.
  • Parkside Financial Bank & Trust first reported a position in Ligand Pharmaceuticals in Q4 2016 and has held it in 23 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.